Ilyas K. Colombowala, MD, FACC, FHRS
Cardiac Electrophysiology · Houston, TX · colombowala.com

Procedure

Pulsed Field Ablation (PFA)

Non-thermal ablation using irreversible electroporation. Tissue selectivity spares the esophagus, phrenic nerve, and vessels — reshaping AF ablation and expanding into flutter and VT.

Typical duration
~1–2 h lab time; energy delivery itself is fast
Sedation
General with paralysis (muscle contraction accompanies delivery)

Equipment & setup

  • PFA generator and console (Farapulse, Affera/Sphere-9, Volt, or equivalent)
  • Pentaspline, focal, or lattice-tip PFA catheter
  • Steerable sheath for left atrial work
  • Transseptal needle/dilator and intracardiac echo (ICE)
  • 3D electroanatomic mapping system for map-integrated platforms (Affera, EnSite)
  • Circular mapping catheter for isolation confirmation
  • Heparin and ACT monitor
  • ECG for gated delivery; nitroglycerin available for cases near coronary arteries

Common pitfalls

  • Diaphragmatic/skeletal muscle contraction with each application — paralysis under GA minimizes catheter displacement
  • Coronary spasm when ablating near arteries (mitral isthmus, CTI near the RCA) — pretreat with nitroglycerin
  • Hemolysis with high cumulative application counts — hydrate, watch for hemoglobinuria
  • Microbubble/gas formation on delivery — respect cumulative dose limits
  • Treating PFA as foolproof — antral coverage and confirmed isolation still matter
  • Air embolism on large-bore sheath exchanges — meticulous flushing

What PFA is

Pulsed field ablation destroys myocardium by irreversible electroporation rather than heat. Trains of short, high-voltage pulses create permanent pores in the cell membrane, leading to cell death. Because the electroporation threshold differs by tissue type, myocardium can be ablated at energies that largely spare the esophagus, phrenic nerve, pulmonary veins, and coronary arteries — the structures that drive the most feared thermal complications.

This is the central selling point: the atrioesophageal fistula and phrenic palsy that haunt RF and cryo are nearly designed out.

Indications

  • Paroxysmal and persistent AFpulmonary vein isolation, increasingly first-line
  • Atrial flutter and atrial tachycardia — cavotricuspid isthmus and linear lesions (with attention to coronary proximity)
  • Emerging: ventricular substrate and posterior wall isolation on combined platforms

How it differs in the lab

  • Anesthesia: generalized muscle contraction accompanies each application, so general anesthesia with paralysis is the norm — patient and catheter stay still.
  • Gating: deliveries are synchronized to the ECG to avoid the ventricular vulnerable period.
  • Speed: each application is milliseconds; full PVI is often faster than RF or cryo.
  • No thermal monitoring: esophageal temperature probes and phrenic pacing become less critical, though many operators still phrenic-pace early in their experience.

Pre-procedure prep

  • Anticoagulation continuous through the procedure, as with thermal AF ablation
  • TEE or cardiac CT to exclude LAA thrombus and define anatomy
  • NPO, standard labs and ECG; anesthesia consult for GA with paralysis

Setup & equipment

  • Ultrasound-guided femoral venous access; ICE for transseptal and effusion surveillance
  • Heparin to ACT 300–350 before and throughout left atrial work
  • Transseptal puncture under ICE/fluoro; steerable sheath into the LA
  • Position the PFA catheter at each PV antrum

Technique

  • Deploy the catheter at the antrum and cycle through configurations (e.g., basket and flower for the pentaspline) for circumferential coverage
  • Deliver the programmed application count per vein, repositioning as guided by mapping
  • The anterior antrum is the most commonly under-treated region — verify coverage
  • For mitral isthmus or CTI lines near coronaries, give nitroglycerin and respect proximity to reduce spasm risk

Confirming isolation

  • Document entrance and exit block on the circular mapping catheter, as with any PVI
  • Re-check after a waiting period; an adenosine challenge can unmask dormant conduction
  • Tissue effect is immediate, but confirmation discipline is unchanged

Complications

  • Coronary spasm — the PFA-specific watch-item near arteries; usually responds to nitroglycerin
  • Hemolysis — dose-related; hydrate and monitor for hemoglobinuria with high application counts
  • Tamponade — from transseptal or mechanical trauma, not the energy itself
  • Stroke/TIA — uninterrupted anticoagulation mitigates
  • Atrioesophageal fistula and phrenic palsy — markedly reduced versus thermal energy, the core advantage

Post-procedure care

  • Bed rest with groin hemostasis, then ambulate
  • Same-day discharge is common in straightforward cases
  • Anticoagulation continues at least 2–3 months, then per long-term stroke risk
  • Standard blanking-period counseling and rhythm follow-up at 4–6 weeks

Last reviewed by Dr. Colombowala on May 27, 2026.

Clinical-reference content, not medical advice. This page is written for EP staff and does not create a doctor-patient relationship. It does not replace institutional policy, current device manuals, or attending direction during a case. See the full disclaimer.

© 2026 Ilyas K. Colombowala, MD. All rights reserved. Reproduction, redistribution, or republication of this content in any form without written permission is prohibited.

Source: